Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 367514 87 2. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot synthesis for Lurasidone intermediates reduces costs and improves purity. Ideal for reliable pharmaceutical intermediates supplier partnerships globally.
Patent CN102746289B reveals a robust crystallization process for Lurasidone Hydrochloride, ensuring high purity and low solvent residue for cost reduction in pharmaceutical manufacturing.